Partner Headlines - GEVA

  1. Synageva BioPharma Announces Dosing Of Patients Commenced With ...

    Benzinga
  2. Clear Channel Outdoor, Oasis Petroleum And Other Insiders Have ...

    Benzinga
  3. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  4. 4 More Biotech Secondaries Investors Are Watching

    Benzinga
  5. Benzinga's Volume Movers

    Benzinga
  6. 4 Biotech Secondary Offerings Traders Are Watching

    Benzinga
  7. Synageva BioPharma Completes Rolling Submission Of Biologics ...

    Benzinga
  8. Synageva BioPharma Presents Sebelipase Alfa Data At The NASPGHAN ...

    Benzinga
  9. Synageva Shares Tumble Amid Positive Phase 3 Data, A Director's ...

    Benzinga
  10. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  11. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; ...

    Benzinga
  12. Markets Surge; GM June Sales Rise 1%

    Benzinga
  13. Morning Market Losers

    Benzinga
  14. SYNAGEVA BIOPHARMA

    IBD
  15. Synageva BioPharma Reports Phase 3 Study Meets Primary Endpoint ...

    Benzinga
  16. UPDATE: Morgan Stanley Reiterates on Synageva BioPharma as Brain-Blood ...

    Benzinga
  17. UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public ...

    Benzinga
  18. Synageva BioPharma Completes Target Enrollment in Phase 3 ARISE ...

    Benzinga
  19. Benzinga's Top Initiations

    Benzinga
  20. UPDATE: Goldman Sachs initiates on Synageva Following Positive ...

    Benzinga
  21. UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on ...

    Benzinga
  22. UPDATE: Wedbush Downgrades Synageva BioPharma on Valuation

    Benzinga
  23. Benzinga's Volume Movers

    Benzinga
  24. Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share

    Benzinga
  25. Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 ...

    GuruFocus
  26. UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on ...

    Benzinga
  27. Synageva Prices 2.15M Share Public Offering at $47.53/Share

    Benzinga
  28. UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack ...

    Benzinga
  29. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  30. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  31. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  32. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises ...

    Benzinga
  33. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  34. Benzinga's Top Initiations

    Benzinga
  35. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  36. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells ...

    GuruFocus
  37. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  38. Synageva BioPharma Corp. (GEVA) SVP, CFO Carsten Boess sells ...

    GuruFocus
  39. Merck &, Quest Diagnostics Among Stocks Setting 52-Week Highs ...

    FoxBusiness
  40. Synageva BioPharma, WesBanco Hit 52-week Highs Wednesday

    FoxBusiness
  41. Synageva BioPharma, Deltek Hit 52-week Highs Tuesday

    FoxBusiness
  42. ASML, Wolverine World Wide Included in Stocks Up on High Volume ...

    FoxBusiness
  43. Synageva BioPharma Announces $80 Million Proposed Public Offering ...

    Benzinga
  44. Four Winning Trades Based on Analyst Calls

    Benzinga
  45. CF Industries Holdings, SBA Communications Corporation Included ...

    FoxBusiness
  46. Winning Trades Based on Analyst Ratings for June 25

    Benzinga
  47. Synageva BioPharma Jumps on Canaccord Genuity Initiation

    Benzinga
  48. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs ...

    FoxBusiness
  49. UPDATE: Canaccord Genuity Initiates Synageva BioPharma at BUy, ...

    Benzinga
  50. Synageva BioPharma Corp. (GEVA) President & CEO Sanj K Patel ...

    GuruFocus
  51. Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal ...

    Benzinga
Trading Center